Skip to content
healthcare.dev
Get a free key

CIMERLI

NDC 70114-441, ranibizumab-eqrn, injection, solution, from Coherus BioSciences Inc.

Product NDC
70114-441
Status
Listed
Labeler
Coherus BioSciences Inc
Dosage form
INJECTION, SOLUTION
Route
INTRAVITREAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761165
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70114-441 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • RANIBIZUMAB.5 mg/.05mL

Pharmacologic classes

Vascular Endothelial Growth Factor Inhibitor [EPC]; Vascular Endothelial Growth Factor Inhibitors [MoA]

Package NDCNDC-11Package
70114-441-01701140441011 VIAL, SINGLE-DOSE in 1 CARTON (70114-441-01) / .05 mL in 1 VIAL, SINGLE-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/e0e23118-1490-a554-e053-2995a90ab90c

  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=70114-441

Use it

Look up 70114-441 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70114-441 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70114-441. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.